Target intelligence / Profile preview

Single-stranded DNA aptamer (ssDNA aptamer)

Target
ssDNA aptamer
Molecular classification
Other (nucleic acid-based ligand)
01

Overview

A single-stranded DNA aptamer is a short, synthetic single-stranded DNA oligonucleotide that forms three-dimensional structures capable of binding to a wide variety of molecular targets—including proteins, peptides, small molecules, and even cells—with high affinity and specificity. Aptamers are discovered and optimized by in vitro selection processes such as SELEX, and they function analogously to antibodies but are composed of nucleic acids rather than proteins. They are used as molecular recognition elements in diagnostics, therapeutics, targeted drug delivery, and biosensors. Single-stranded DNA aptamers are generally more stable than RNA aptamers in biological environments but may require chemical modifications for enhanced plasma stability and resistance to nucleases. While aptamers can be used as therapeutic agents, the term "single-stranded DNA aptamer" does not denote a unique therapeutic target.

Other names
DNA aptamerssDNA aptameraptamer
02

Mechanism of action

Aptamers act by binding to specific molecular targets; their mechanism depends on the chosen target, e.g. blocking a receptor, inhibiting a protein, or delivering a drug

03

Biological functions

Molecular recognitionTarget binding (proteins, small molecules, cells, etc.)BiosensingTargeted deliveryDiagnostic applicationsTherapeutic agent (as cargo or direct binding agent)
04

Disease associations

Other (versatile platform technology; may be used in cancer, infection, inflammation, etc. depending on context, but not a disease target itself)
05

Safety considerations

Susceptibility to nuclease degradation (improved by chemical modifications)Rapid renal clearance due to small size (addressed by PEGylation or other modifications)Immunogenicity generally low but should be evaluated for each aptamer and chemical modification

Beyond the preview

Go deeper on Single-stranded DNA aptamer (ssDNA aptamer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Single-stranded DNA aptamer (ssDNA aptamer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call